Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SAPHIR PHARMA FRANCE - SPF : revenue, balance sheet and financial ratios

SAPHIR PHARMA FRANCE - SPF is a French company founded 7 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in TOURS (37000), this company of category PME shows in 2022 a net income negative of -29€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SAPHIR PHARMA FRANCE - SPF (SIREN 850366600)
Indicator 2022 2021 2020 2019
Revenue N/C N/C N/C N/C
Net income -29 € 24 € -84 € -397 €
EBITDA -2 427 € -1 575 € -1 080 € -1 797 €
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2022, SAPHIR PHARMA FRANCE - SPF records a net loss of 29 €. This deficit will reduce equity on the balance sheet.

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 427 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 427 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-29 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

0.0%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
SAPHIR PHARMA FRANCE - SPF

Sector positioning

Debt ratio
0.0 2022
2020
2021
2022
Q1: 0.0
Med: 6.23
Q3: 53.97
Excellent

In 2022, the debt ratio of SAPHIR PHARMA FRANCE - SPF (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
0.0% 2022
2020
2021
2022
Q1: 15.33%
Med: 37.18%
Q3: 59.34%
Average

In 2022, the financial autonomy of SAPHIR PHARMA FRANCE - SPF (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2022
2020
2021
2022
Q1: 0.0 years
Med: 0.01 years
Q3: 1.6 years
Excellent

In 2022, the repayment capacity of SAPHIR PHARMA FRANCE - SPF (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 271.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

271.333

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-0.082

Liquidity indicators evolution
SAPHIR PHARMA FRANCE - SPF

Sector positioning

Liquidity ratio
271.33 2022
2022
Q1: 136.77
Med: 203.41
Q3: 332.18
Good

In 2022, the liquidity ratio of SAPHIR PHARMA FRANCE - SPF (271.33) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-0.08x 2022
2020
2021
2022
Q1: 0.0x
Med: 0.34x
Q3: 4.26x
Average

In 2022, the interest coverage of SAPHIR PHARMA FRANCE - SPF (-0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SAPHIR PHARMA FRANCE - SPF in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare SAPHIR PHARMA FRANCE - SPF with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about SAPHIR PHARMA FRANCE - SPF

What is the revenue of SAPHIR PHARMA FRANCE - SPF ?

The revenue of SAPHIR PHARMA FRANCE - SPF is not publicly disclosed (confidential accounts filed with INPI).

Is SAPHIR PHARMA FRANCE - SPF profitable?

SAPHIR PHARMA FRANCE - SPF recorded a net loss in 2022.

Where is the headquarters of SAPHIR PHARMA FRANCE - SPF ?

The headquarters of SAPHIR PHARMA FRANCE - SPF is located in TOURS (37000), in the department Indre-et-Loire.

Where to find the tax return of SAPHIR PHARMA FRANCE - SPF ?

The tax return of SAPHIR PHARMA FRANCE - SPF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SAPHIR PHARMA FRANCE - SPF operate?

SAPHIR PHARMA FRANCE - SPF operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.